Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: J Card Fail. 2011 Sep 3;17(11):879–886. doi: 10.1016/j.cardfail.2011.07.008

Table 4.

Changes in Cardiac Biomarker Levels with Treatment

Baseline Final % Change
Statin Placebo P
value*
Statin Placebo P value Statin Placebo
B-type natriuretic peptide, pg/mL 175 (36 – 472) 66 (29 – 154) 0.227 107 (34 – 173) 67 (21 – 299) 0.605 −38.9% +1.5%
High sensitivity C-reactive protein, mg/L 1.6 (0.6 – 4.4) 1.9 (1.0 – 3.0) 0.700 1.9 (0.5 – 5.7) 3.4 (1.1 – 5.9) 0.307 +18.8% −78.9%
Troponin I ≥ 0.04 ng/mL, % 8 21 0.356 0 15 0.511 - -
*

Baseline p values were determined by Mann-Whitney U test, and chi-square for Troponin I.

Changes between the two groups from baseline were determined by Mann-Whitney U test, and Chi-Square for Troponin I.